Notification of Major Holdings

1. Details of issuer

MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany

2. Reason for notification

X Acquisition/disposal of shares with voting rights
Acquisition/disposal of instruments
Change of breakdown of voting rights
Other reason:

3. Details of person subject to the notification obligation

Name: City and country of registered office:
Varian Medical Systems, Inc. Wilmington, Delaware
United States of America (USA)

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.

5. Date on which threshold was crossed or reached:

6. Total positions

% of voting rights attached to shares
(total of 7.a.) 		% of voting rights through instruments
(total of 7.b.1 + 7.b.2) 		total of both in %
(7.a. + 7.b.) 		total number of voting rights of issuer
Resulting situation 0 % 0 % 0 % 1820000
Previous notification 73.52 % n/a % n/a % /

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN absolute in %
direct
(Sec. 21 WpHG) 		indirect
(Sec. 22 WpHG) 		direct
(Sec. 21 WpHG) 		indirect
(Sec. 22 WpHG)
DE000A9LBFE4 0 0 0 % 0 %
Total 0 0 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG

Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
%
Total %

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG

Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
%
Total %

8. Information in relation to the person subject to the notification obligation

X Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting:
Holding position after general meeting: % (equals voting rights)

10. Other explanatory remarks:

The shares of the issuer were transferred from VMS Deutschland Holdings GmbH to Varex Imaging Deutschland AG.

MeVis Medical Solutions AG published this content on 13 October 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 13 October 2017 15:19:07 UTC.

Original documenthttp://www.mevis.de/en/investor-relations/ir-announcements/ir-announcement/?tx_ttnews[tt_news]=795&cHash=470314b3ec7e66cb89b24e0ad40ecdef

Public permalinkhttp://www.publicnow.com/view/3E1203BF233D8C62662522A54B92E136E32F1AFB